Chicago: Does Saying “I Do” Lower Late-life Dementia Risk?
event that, if sustained, seems to add to the AD risk conferred by the ApoE4 gene.—Esther Landhuis. None
ALL NEWS
378 RESULTS
You searched Esther
Sort By:
- Most Recent
- Most Commented
- Most Relevant
Chicago: Tau Projection Domain May Block Excitotoxicity in Mice
toxicity in primary neuronal cultures in a dose-dependent fashion.—Esther Landhuis. This concludes our
Chicago: Brain-Penetrant Microtubule Stabilizer in Tauopathy Mice
in the brain in AD and related diseases. For more on that, see Part 3 of this series.—Esther Landhuis.
Chicago: Translational and Basic Science of Tau Advances
For a different approach to treating tauopathy mice, see Part 2 of this series.—Esther Landhuis. This is Part 1
Chicago: APP Roles in Caspase Gene Regulation, Muscle Function?
C-terminus—which binds Fe65 and other cytoplasmic proteins—could still mediate key APP functions.—Esther Landhuis.
Paper Alert: PIB-PET, Brain Biopsies Match Well for Detecting Aβ
with AD-like features in this study had severe dementia.—Esther Landhuis None
Chicago: Dimebon Safe for 18 Months
goes well, that is.—Esther Landhuis and Gabrielle Strobel. None
Chicago: Studies Probe Diminishing Placebo Decline, Part 2
meeting in Washington, DC.—Esther Landhuis. This is a two-part story. See also Part 1. None
Chicago: Studies Probe Diminishing Placebo Decline, Part 1
in the management of AD risk factors, and general advances in medical care for older people, Jones noted.—Esther
AD Clinical Pipeline: Immunotherapy Woes, Dimebon Boons
receptor antagonists.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=1879 Alzheimer's
Pump It Up—Presenilins Linked to ER SERCA Activity
mechanisms.”—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=1876 Alzheimer's Disease Ion Channels
SIRT1, Resveratrol and More: Moving Closer to Anti-aging Elixir?
and geranylgeranylation.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=1874 Aging Sirtuins
AD Research Participation: Informed Consent Complicates Trials, Part 2
of facilitating AD research by clearly permitting surrogate consent.—Esther Landhuis See also Part 1
AD Research Participation: Informed Consent Complicates Trials, Part 1
of this story.—Esther Landhuis See also Part 2 of this story. None http://www.alzforum.org/new/detail.asp?id=1867
Paper Alert: Anti-Inflammatory Blocks Aβ Deposition in AD Mice
of CNI-1493 as an AD drug.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=1865